L

Limbic

www.limbic.ai link_icon

Company Research Report: Limbic



Company Overview



  • Name: Limbic

  • Mission: To make mental healthcare more human by reducing staff burnout, improving community engagement, and driving better patient outcomes with clinical AI.

  • Founded: Launched in 2020

  • Founders: Founded by a team of 10 PhDs across neuroscience, psychiatry, machine learning, and medicine.

  • Key People:

  • Dr. Ross Harper, CEO

  • Sebastiaan de Vries, CTO

  • Bruce Armstrong, NED

  • Adina Tecklu, Associate NED

  • Dr. Max Rollwage, VP of AI & Research

  • Scott Osler, VP of Commercial

  • Dr. Tobias Hauser, Head of Computational Psychiatry

  • Ben Carrington, US General Manager

  • Headquarters: London, with a global presence

  • Number of Employees: No information is available

  • Revenue: No information is available

  • Known For: Innovating mental health care with AI technologies targeted at reducing clinical assessment times and improving patient satisfaction across the care continuum.


Products



Limbic Access


  • Description: AI-assisted tool for patient intakes and clinical assessments.

  • Key Features:

  • Reduces patient assessment times by 50%.

  • Improves diagnostic accuracy and patient outcomes.

  • Facilitates 24/7 patient access and enhanced engagement.


Limbic Care


  • Description: An AI companion providing on-demand support between therapy sessions.

  • Key Features:

  • Seamlessly integrates with patient-specific treatment plans.

  • Delivers personalized conversational support.

  • Aims to improve clinical outcomes more efficiently.


Limbic Layer


  • Description: Platform with scientific foundations from a team of PhDs across various fields.

  • Key Features:

  • Uses generative AI to ensure compliance in healthcare settings.

  • Advances safety and outcome measures through scientifically validated AI technologies.


Recent Developments



  • New Products Launched: Introduction of Limbic Care, designed to offer generative AI support for mental health services.

  • New Features & Innovations:

  • Developed AI chatbot that became the first globally to achieve Class IIa UKCA medical device status.

  • Published studies demonstrating improvements in mental health assessments and clinical efficiencies using conversational AI.

  • Integrated across 95% of patient management systems, including NHS Spine, enhancing interoperability.

  • Partnerships: Collaboration with NHS providers and major behavioral health organizations to improve access, clinician satisfaction, and patient outcomes.


Real-World Impact



  • Patient and Clinician Outcomes:

  • Over 350,000 patients supported with improved recovery rates and reduced changes in treatment pathways.

  • A significant increase in self-referrals among underserved populations achieved.

  • Clinician well-being improvement reported with time saved on assessments redirected to patient care.

  • Recognition: Featured in a Nature Medicine study for driving substantial gains in self-referrals through its AI chatbot.


Conclusion



Limbic's clinical AI solutions embody a shift towards more efficient, empathetic mental healthcare by freeing clinicians from administrative burdens and focusing on therapy, thus benefiting both patients and clinicians, as demonstrated in various healthcare settings such as NHS Trusts and large behavioral health organizations.